21 October 2017
News and Views
Links and Services
fiogf49gjkf04Metformin improves survival in patients with pancreatic ductal adenocarcinoma and pre-existing diabetes, reports this month's American Journal of Gastroenterology.
Pancreatic ductal adenocarcinoma remains a highly lethal disease.
Diabetes mellitus is bot
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors